GeoVax Labs Shares Are Trading Higher. Earlier in the Week, the Company Received a BARDA Project NextGen Award to Conduct a Phase 2b Clinical Study Evaluating Its COVID-19 Vaccine Candidate, GEO-CM04S1.
GeoVax Labs Shares Are Trading Higher. Earlier in the Week, the Company Received a BARDA Project NextGen Award to Conduct a Phase 2b Clinical Study Evaluating Its COVID-19 Vaccine Candidate, GEO-CM04S1.
geovax labs股價上漲。本週早些時候，該公司獲得了BARDA NextGen項目獎，以開展關於其COVID-19疫苗候選物GEO-CM04S1的2b期臨床研究評估。
GeoVax Labs Shares Are Trading Higher. Earlier in the Week, the Company Received a BARDA Project NextGen Award to Conduct a Phase 2b Clinical Study Evaluating Its COVID-19 Vaccine Candidate, GEO-CM04S1.
geovax labs股價上漲。本週早些時候，該公司獲得了BARDA NextGen項目獎，以開展關於其COVID-19疫苗候選物GEO-CM04S1的2b期臨床研究評估。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。